As a result, the critical involvement of TMPRSS2 in the infectivity and pathophysiology of viral respiratory infections such as SARS-CoV-2 and influenza makes it an attractive target for therapeutic interventions to reduce death and disability caused by these respiratory viruses [61]. The gene discussed is TMPRSS2; the disease is influenza.